In this "Practice Pearls" roundtable organized by Pharmacy Times, expert panelists discuss acute myeloid leukemia (AML) diagnosis and the various factors affecting decision-making for specialists treating patients with AML.

Learn more by clicking here.

Panelists:

  • Katie Culos, PharmD, BCOP
    Hematology/Oncology Clinical Pharmacist – Vanderbilt University Medical Center
    Nashville, Tennessee
  • Amanda Brahim, PharmD, BCOP, BCPS, BCACP
    Hematology/Oncology Clinical Pharmacist – Memorial Cancer Institute
    Pembroke Pines, Florida
  • Yehuda Deutsch, MD
    Hematologist/Oncologist – Department of Malignant Hematology and Cellular Therapy – Memorial Cancer Institute
    Pembroke Pines, Florida